Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer

Acta Oncologica

Volumn 47, Issue 8, 2008, Pages 1531-1538

  Kim, Sung Hyun ^a   Seo, Bo Kyoung ^a   Lee, Juneyoung ^a   Kim, Seok Jin ^a   Cho, Kyu Ran ^a   Lee, Ki Yeol ^a   Je, Bo Kyung ^a   Kim, Hee Young ^a   Kim, Young Sik ^a   Lee, Ju Han ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; CANCER GRADING; CANCER INVASION; CARCINOMA IN SITU; CELL DIFFERENTIATION; CORRELATION ANALYSIS; ECHOGRAPHY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 54349095431     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801971413     Document Type: Article

References (24)

1. Clark G. Diseases of the Breast, 2nd edn. Philadelphia: Lippingcott Williams & Wilkins; 2000.
2. Mouret-Reynier MA, Abrial CJ, Ferrière JP, Amat S, Curé HD, Kwiatkowsi FG, et al. Neoadjuvant FEC 100 for operable breast cancer: 8-year experience at Centre Jean Perrin. Clin Breast Cancer 2004;5:303-7.
3. van Diest PJ, van der Wall E, Baak JP. Prognostic value of proliferation in invasive breast cancer: A review. J Clin Pathol 2004;57:675-81.
4. Rosen PP. Rosen's Breast Pathology, 2nd edn. Philadelphia: Lippingcott Williams & Wilkins; 2001.
5. Pegram MD, Konecny GE, O'Callaghan C, Beryt M, Pietras R, Slamon DJ. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. J Natl Cancer Inst 2004;96:739-49.
6. Buchberger W, DeKoekkoek-Doll P, Springer P, Obrist P, Dünser M. Incidental findings on sonography of the breast: Clinical significance and diagnostic workup. AJR 1999;173:921-7.
7. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound. Cancer 1995;76:626-30.
8. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: Detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998;207:191-9.
9. Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. AJR 2003;181:177-82.
10. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-34.
11. American College of Radiology. Breast imaging reporting and data system (BI-RADS®)-Ultrasound. 1st ed. Reston: ©American College of Radiology; 2003.
12. Bloom HJG, Richardson WW. Histologic grading and prognosis in breast cancer: A study of 1709 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:353-77.
13. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.
14. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R. Immunocystochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990;50:7057-61.
15. Guerra I, Algorta J, Díaz de Otazu R, Pelayo A, Farin̈a J. Immunohistochemical prognostic index for breast cancer in young women. Mol Pathol 2003;56:323-7.
16. Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, et al. Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer 2003;98:2547-53.
17. Chen SC, Cheung YC, Lo YF, Chen MF, Hwang TL, Su CH, et al. Sonographic differentiation of invasive and intraductal carcinomas of the breast. Br J Radiol 2003;76:600-4.
18. Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG. US of ductal carcinoma in situ. Radiographics 2002;22:269-80.
19. Lamb PM, Perry NM, Vinnicombe SJ, Wells CA. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of breast. Clin Radiol 2000;55:40-4.
20. Watermann DO, Tempfer CB, Hefler LA, Parat C, Stickeler E. Ultrasound criteria for ductal invasive breast cancer are modified by age, tumor size, and axillary lymph node status. Breast Cancer Res Treat 2005;89:127-33.
21. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-92.
22. Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 2006;13:1211-8.
23. Karamouzis MV, Likaki-Karatza E, Ravazoula P, Badra FA, Koukouras D, Tzorakoleftherakis E, et al. Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer 2002;102:86-90.
24. Yaziji H, Goldstein LC, Barry TS, Werling R, Hwang H, Ellis GK, et al. HER-2 testing in breast cancer using parallel tissue-based methods. JAMA 2004;291:1972-7.